FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
|
Thread Tools | Display Modes |
05-06-2017, 01:04 PM | #1 | |||
|
||||
Grand Magnate
|
MT Pharma America Announces FDA Approval of RADICAVA™ (Edaravone), the First New Treatment Option for ALS in More Than 20 Years
MT Pharma America Announces FDA Approval of RADICAVA™ (Edaravone), the First New Treatment Option for ALS in More Than 2 Years | Small Molecules | News Channels |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
MT Pharma Presents Data on Edaravone for ALS at 2017 AAN Meeting | ALS News & Research | |||
Schwarz Pharma' Neupro to get approval for treatment of Parkinson's disease | Parkinson's Disease |